Patents by Inventor Ou Wang

Ou Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12516446
    Abstract: Provided are a method for detecting spatial information of nucleic acids in a sample, as well as a nucleic acid array used in the method and a method for producing the nucleic acid array.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 6, 2026
    Assignees: BGI SHENZHEN, MGI TECH CO., LTD.
    Inventors: Ao Chen, Xun Xu, Sha Liao, Jin Yang, Longqi Liu, Ou Wang, Yuxiang Li, Guoxin Tang, Yuan Jiang, Chongjun Xu, Ming Ni, Wenwei Zhang, Radoje Drmanac, Snezana Drmanac
  • Patent number: 12497713
    Abstract: Methods and compositions for preparing a nucleic acid sequencing library are described including (a) transposing an insertion sequence into first fragments of the target nucleic acid, wherein the insertion sequence comprises a hybridization sequence, and wherein the transposing produces nicks in the first fragments; (b) combining in a single mixture (i) the first fragments of the target nucleic acid from (a), (ii) a splint oligonucleotide, and (iii) a population of beads, wherein each bead comprises capture oligonucleotides immobilized thereon, and (c) ligating capture oligonucleotides of individual beads to inserted hybridization sequences of individual first fragments.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: December 16, 2025
    Assignees: MGI Tech Co., Ltd., BGI Shenzhen
    Inventors: Radoje T. Drmanac, Brock A. Peters, Ou Wang
  • Publication number: 20250136974
    Abstract: The present invention relates to a nucleic acid molecule capable of blocking motor protein, a library containing the nucleic acid molecule, a method for constructing the nucleic acid molecule or library containing the same, and an application of the nucleic acid molecule or library containing same.
    Type: Application
    Filed: December 31, 2021
    Publication date: May 1, 2025
    Inventors: Ou Wang, Xiao Shi, Xun Xu, Wenwei Zhang, Fei Guo, Siyu Bao, Yuliang Dong, Tao Zeng
  • Publication number: 20250066747
    Abstract: Provided is helicase BCH1X, which comprises an amino acid sequence represented by SEQ ID NO: 1 or 2. Further provided are a complex structure comprising helicase BCH1X and a binding moiety used for binding to a polynucleotide, and a use thereof in the control and characterization of a polynucleotide and in single molecule nanopore sequencing.
    Type: Application
    Filed: December 31, 2021
    Publication date: February 27, 2025
    Inventors: Xun Xu, Fei Guo, Qiaoxia Hu, Denghui Li, Junyi Chen, Lele Wang, Ziyu Zhao, Zhouxiang Ji, Tao Zeng, Ou Wang, Yuxiang Li, Yuliang Dong, Wenwei Zhang
  • Publication number: 20250066748
    Abstract: The present invention provides a helicase BCH2X, comprising an amino acid sequence represented by any one of SEQ ID NOs: 1-3. The present invention also provides a complex structure comprising the helicase BCH2X and a binding moiety for binding polynucleotides. The present invention also provides a use of the helicase BCH2X or the complex structure comprising same in the control and characterization of polynucleotides and single-molecule nanopore sequencing.
    Type: Application
    Filed: December 31, 2021
    Publication date: February 27, 2025
    Inventors: Lele Wang, Tao Zeng, Zhenjun Liu, Junyi Chen, Ziyu Zhao, Denghui Li, Fei Guo, Zhouxiang Ji, Ou Wang, Yuxiang Li, Yuliang Dong, Wenwei Zhang, Xun Xu
  • Publication number: 20250032456
    Abstract: The present invention provides methods, compositions (e.g., eyedrop or spongarion composition), and uses for alleviating and preventing age-associated vitreous degeneration in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, polymer, analog or derivative thereof, as an active ingredient. In particular, L-ergothioneine is capable of scavenging chronic reactive oxygen species directly and radically to mitigate and prevent HA depolymerization and HA decreasing-viscosity in the mammal's vitreous body; and/or improving vitreous liquefaction in the mammal.
    Type: Application
    Filed: October 9, 2024
    Publication date: January 30, 2025
    Inventors: Ronghua YI, Qiru FAN, Mingru WANG, Ou WANG, Kylin LIAO
  • Publication number: 20250027229
    Abstract: Described herein are high coverage single tube Long Fragment Read (stLFR) technology which uses performs stLFR on target DNA fragments that have already been amplified before they are co-barcoded, which provides higher amount of DNA for sequencing and increases sequencing coverage. In some embodiments, the high coverage stLFR described in this application uses two rounds of stLFR. In some embodiments, the target DNA fragments are transposed with transposons having particular positional barcodes that can be used to order sequence reads.
    Type: Application
    Filed: April 8, 2024
    Publication date: January 23, 2025
    Inventors: Brock A. Peters, Ou Wang, Radoje T. Drmanac
  • Patent number: 12168001
    Abstract: The present invention provides methods, compositions (e.g., eyedrop or spongarion composition), and uses for alleviating and preventing age-associated vitreous degeneration in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, polymer, analog or derivative thereof, as an active ingredient. In particular, L-ergothioneine is capable of scavenging chronic reactive oxygen species directly and radically to mitigate and prevent HA depolymerization and HA decreasing-viscosity in the mammal's vitreous body; and/or improving vitreous liquefaction in the mammal.
    Type: Grant
    Filed: December 20, 2023
    Date of Patent: December 17, 2024
    Assignee: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Ronghua Yi, Qiru Fan, Mingru Wang, Ou Wang, Kylin Liao
  • Publication number: 20240279724
    Abstract: Provided is a method for obtaining a double-stranded sequence by single-stranded rolling circle amplification, comprising: 1) performing rolling circle amplification reaction on single-stranded circular DNA by means of a first primer to obtain an amplified sequence, the first primer being complementary to a partial region of the single-stranded circular DNA, and the single-stranded circular DNA having a break mechanism that can cause the single-stranded circular DNA to ring-open; 2) ring-opening the single-stranded circular DNA by means of the break mechanism to obtain single-stranded linear DNA; and 3) using the single-stranded linear DNA as a second primer and using the amplified sequence obtained in step 1) as a template to perform amplification reaction to obtain an amplified double-stranded sequence.
    Type: Application
    Filed: June 16, 2021
    Publication date: August 22, 2024
    Inventors: Ji Wang, Tao Tan, Lin Zhou, Ou Wang, Wenwei Zhang, Ao Chen
  • Publication number: 20240138449
    Abstract: The present invention provides novel methods for preparing a moisture-proof amino acid material. The present invention also provides novel compositions or nutritional supplements comprising the moisture-proof amino acid materials prepared by the methods of this invention.
    Type: Application
    Filed: March 17, 2022
    Publication date: May 2, 2024
    Applicant: NANJING NUTRABUILDING BIO-TECH CO., LTD.
    Inventors: Jun Tang, Wei Wang, Ou Wang, Qiru Fan, Kylin Liao
  • Publication number: 20240122900
    Abstract: The present invention provides methods, compositions (e.g., eyedrop or spongarion composition), and uses for alleviating and preventing age-associated vitreous degeneration in a mammal, comprising administrating to the mammal in need thereof a therapeutically effective amount of L-ergothioneine, an analog or derivative thereof, or a pharmaceutically acceptable salt, acid, ester, polymer, analog or derivative thereof, as an active ingredient. In particular, L-ergothioneine is capable of scavenging chronic reactive oxygen species directly and radically to mitigate and prevent HA depolymerization and HA decreasing-viscosity in the mammal's vitreous body; and/or improving vitreous liquefaction in the mammal.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Inventors: Ronghua YI, Qiru FAN, Mingru WANG, Ou WANG, Kylin LIAO
  • Patent number: 11718872
    Abstract: A method for obtaining a single-cell mRNA sequence, including: (1) capturing mRNA of a cell by using a cell tag carrier, and performing reverse transcription to obtain cDNA having a cell tag; (2) obtaining multiple cDNA fragments having molecular tags by using a transposase complex and a molecular tag carrier; (3) performing high-throughput sequencing; (4) performing sequence assembly according to the molecular tags to obtain the sequence of each mRNA; and (5) obtaining the sequence of all mRNAs of each single cell according to the cell tags.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: August 8, 2023
    Assignee: MGI TECH CO., LTD.
    Inventors: Fei Fan, Xiaofang Cheng, Wenwei Zhang, Weimao Wang, Luman Cui, Ou Wang
  • Publication number: 20230175047
    Abstract: Provided are a method for detecting spatial information of nucleic acids in a sample, as well as a nucleic acid array used in the method and a method for producing the nucleic acid array.
    Type: Application
    Filed: May 14, 2020
    Publication date: June 8, 2023
    Inventors: Ao CHEN, Xun XU, Sha LIAO, Jin YANG, Longqi LIU, Ou WANG, Yuxiang LI, Guoxin TANG, Yuan JIANG, Chongjun XU, Ming NI, Wenwei ZHANG, Radoje DRMANAC, Snezana DRMANAC
  • Publication number: 20220275342
    Abstract: Embodiments of the disclosure provide a dissolvable or degradable artificial circulation system for engineering, culturing, and integrating large volume tissues. Also provided are methods of using large engineered tissues prepared using the degradable artificial circulation system for clinical applications and for various applications such as large-scale production of therapeutic or consumable products, drug discovery, and toxicity screening.
    Type: Application
    Filed: July 6, 2020
    Publication date: September 1, 2022
    Inventors: Yuguo LEI, Qiang LI, Ou WANG
  • Publication number: 20220195624
    Abstract: Described herein are high coverage single tube Long Fragment Read (stLFR) technology which uses performs stLFR on target DNA fragments that have already been amplified before they are co-barcoded, which provides higher amount of DNA for sequencing and increases sequencing coverage. In some embodiments, the high coverage stLFR described in this application uses two rounds of stLFR. In some embodiments, the target DNA fragments are transposed with transposons having particular positional barcodes that can be used to order sequence reads.
    Type: Application
    Filed: January 29, 2020
    Publication date: June 23, 2022
    Inventors: Brock A. Peters, Ou Wang, Radoje T. Drmanac
  • Publication number: 20210214783
    Abstract: A method for constructing a sequencing library, a sequencing library and a sequencing method.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 15, 2021
    Inventors: Luman CUI, Fei FAN, Wenwei ZHANG, Zhou LONG, Weimao WANG, Ou WANG
  • Publication number: 20210115595
    Abstract: Methods and compositions for preparing a nucleic acid sequencing library are described including (a)transposing an insertion sequence into first fragments of the target nucleic acid, wherein the insertion sequence comprises a hybridization sequence, and wherein the transposing produces nicks in the first fragments; (b) combining in a single mixture (i) the first fragments of the target nucleic acid from (a), (ii) a splint oligonucleotide, and (iii) a population of beads, wherein each bead comprises capture oligonucleotides immobilized thereon, and (c) ligating capture oligonucleotides of individual beads to inserted hybridization sequences of individual first fragments.
    Type: Application
    Filed: May 7, 2019
    Publication date: April 22, 2021
    Inventors: Radoje T. Drmanac, Brock A. Peters, Ou Wang
  • Publication number: 20200318181
    Abstract: Disclosed is a method for obtaining a single-cell mRNA sequence. The method of the present invention comprises: (1) capturing mRNA of a cell by using a cell tag carrier, and performing reverse transcription to obtain cDNA having a cell tag, cDNAs from the same cell having the same cell tag, and cDNAs from different cells having different cell tags; (2) obtaining multiple cDNA fragments having molecular tags by using a transposase complex and a molecular tag carrier, the fragments from the same cDNA having the same molecular tag, and the fragments from different cDNAs having different molecular tags; (3) performing high-throughput sequencing; (4) performing sequence assembly according to the molecular tags to obtain the sequence of each mRNA; and obtaining the sequence of all mRNAs of each single cell according to the cell tags. The method provided by the present invention can be used for obtaining the sequence of all mRNAs of each of a large number of single cells by means of high throughput.
    Type: Application
    Filed: June 23, 2020
    Publication date: October 8, 2020
    Inventors: Fei Fan, Xiaofang Cheng, Wenwei Zhang, Weimao Wang, Luman Cui, Ou Wang
  • Patent number: 10456769
    Abstract: Provided is a method of constructing a sequencing library. The method includes 1) providing a single-stranded DNA fragment from a biological sample; 2) subjecting the single-stranded DNA fragment to whole genomic amplification to obtain a whole genome amplification product; 3) fragmenting the whole genome amplification product using a transposase embedded with two adaptors to obtain a fragmented product with two adaptors respectively at two ends; and 4) amplifying the fragmented product with two adaptors respectively at two ends using a tag sequence and a pair of primers to obtain said sequencing library.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: October 29, 2019
    Assignee: BGI Shenzhen & BGI Shenzhen Co., Limited
    Inventors: Ou Wang, Xiaofang Cheng, Liangying Zou, Cankun Chang, Hui Jiang, Wenwei Zhang
  • Publication number: 20180195060
    Abstract: Disclosed is a method for constructing a long fragment DNA library, comprising the following steps: 1) breaking a long fragment DNA into target fragments of 3-10 kb by transposase, then amplifying the target fragments, and obtaining target fragment amplification products containing dUTP; 2) amplifying the dUTP in the products by removing the target fragments, fragmenting the target fragments secondarily into DNA short fragments of 300-1200 bp; 3) connecting both ends of the DNA short fragments with sequencing linker single chains A and sequencing linker single chains B respectively; and obtaining connecting sequencing linker products; and 4) PCR amplifying the connecting sequencing linker products, to obtain amplification products.
    Type: Application
    Filed: April 14, 2016
    Publication date: July 12, 2018
    Applicants: BGI SHENZHEN, BGI SHENZHEN CO., LIMITED
    Inventors: Ou WANG, Cankun CHANG, Lin LIN, Hui JIANG, Wenwei ZHANG